中性粒细胞与淋巴细胞比值可作为重症 COVID-19 患者中中重度 ARDS 的预测生物标志物。

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.

机构信息

Department of Critical Care Medicine, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, Sichuan Province, China.

出版信息

Crit Care. 2020 Jun 5;24(1):288. doi: 10.1186/s13054-020-03007-0.

DOI:10.1186/s13054-020-03007-0

PMID:32503668

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7273815/

Abstract

ChiCTR, ChiCTR2000029758. Registered 12 February 2020 - Retrospectively registered.

摘要

ChiCTR，ChiCTR2000029758. 2020 年 2 月 12 日注册-回顾性注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/188a/7275421/f64619e9c78c/13054_2020_3007_Fig1_HTML.jpg

相似文献

[1]

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.

Crit Care. 2020-6-5

[2]

Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.

Respir Res. 2020-7-3

[3]

The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.

Thromb Res. 2020-5-6

[4]

Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.

J Clin Lab Anal. 2020-7-17

[5]

Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.

JAMA Netw Open. 2020-6-1

[6]

Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey.

Crit Care. 2020-8-21

[7]

Predictive value of neutrophil to lymphocyte and platelet to lymphocyte ratio in COVID-19.

Crit Care. 2020-8-28

[8]

The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.

Dtsch Arztebl Int. 2020-4-17

[9]

Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.

Crit Care. 2020-8-26

[10]

Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.

Am J Case Rep. 2020-8-19

引用本文的文献

[1]

Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice.

Fundam Res. 2021-3

[2]

Age influences blood cell-based immune deregulation antibody response and unfavorable clinical outcomes in COVID-19 patients.

Sci Rep. 2025-5-20

[3]

Clinical Impact of Neutrophil Variation on COVID-19 Complications.

Diagnostics (Basel). 2025-2-13

[4]

Use of convalescent plasma in COVID-19 treatment: is clinical severity more important than the intervention?

Einstein (Sao Paulo). 2024-12-16

[5]

Neutrophil-to-Lymphocyte Ratio and Thrombocyte-to-Lymphocyte Ratio as a Predictor of Severe and Moderate/Mild Acute Respiratory Distress Syndrome Patients: Preliminary Results.

J Crit Care Med (Targu Mures). 2024-1-30

[6]

TM9SF1 offers utility as an efficient predictor of clinical severity and mortality among acute respiratory distress syndrome patients.

Front Immunol. 2024

[7]

Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review.

Turk J Emerg Med. 2024-1-8

[8]

First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients.

BMC Infect Dis. 2024-1-31

[9]

Mortality in ICU COVID-19 Patients Is Associated with Neutrophil-to-Lymphocyte Ratio (NLR): Utility of NLR as a Promising Immunohematological Marker.

Interdiscip Perspect Infect Dis. 2023-11-9

[10]

Neutrophil-to-Lymphocyte Ratio as a Predictor of Mortality for COVID-19-Related Acute Respiratory Distress Syndrome (ARDS) Patients Requiring Extracorporeal Membrane Oxygenation Therapy.

Cureus. 2023-9-29

本文引用的文献

[1]

Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.

J Infect. 2020-4-10

[2]

COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.

Am J Respir Crit Care Med. 2020-5-15

[3]

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.

Lancet Respir Med. 2020-3-20

[4]

Preparing for COVID-19: early experience from an intensive care unit in Singapore.

Crit Care. 2020-3-9

[5]

Acute respiratory distress syndrome: the Berlin Definition.

JAMA. 2012-6-20

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

中性粒细胞与淋巴细胞比值可作为重症 COVID-19 患者中中重度 ARDS 的预测生物标志物。

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献